CNR Institutional Research Information System

CERCHIA, LAURA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 301
AS - Asia 181
EU - Europa 122
SA - Sud America 4
AF - Africa 1
OC - Oceania 1
Totale 610
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 300
SG - Singapore 145
IT - Italia 81
KR - Corea 16
DE - Germania 11
FI - Finlandia 8
NL - Olanda 8
HK - Hong Kong 4
BR - Brasile 3
KG - Kirghizistan 3
AE - Emirati Arabi Uniti 2
ES - Italia 2
FR - Francia 2
GB - Regno Unito 2
IE - Irlanda 2
AT - Austria 1
AU - Australia 1
AZ - Azerbaigian 1
BD - Bangladesh 1
CN - Cina 1
CZ - Repubblica Ceca 1
EC - Ecuador 1
ID - Indonesia 1
IL - Israele 1
IN - India 1
IQ - Iraq 1
JO - Giordania 1
JP - Giappone 1
LV - Lettonia 1
MA - Marocco 1
MX - Messico 1
PK - Pakistan 1
PL - Polonia 1
PT - Portogallo 1
SK - Slovacchia (Repubblica Slovacca) 1
VN - Vietnam 1
Totale 610
Salva come PNG Salva come JPEG
Città #
Santa Clara 217
Singapore 103
Giugliano in Campania 23
Marigliano 18
Seoul 16
Falkenstein 10
Naples 9
Helsinki 8
Los Angeles 8
Afragola 7
Casandrino 4
Hong Kong 4
Bishkek 3
Avellino 2
Aversa 2
Dublin 2
Fort Worth 2
London 2
Orta di Atella 2
Santander 2
Soccavo 2
Amman 1
Baghdad 1
Baku 1
Dhaka 1
Dubai 1
Friesland 1
Haifa 1
Islamabad 1
Mexico City 1
Modena 1
New York 1
Nitra 1
Nuremberg 1
Paris 1
Prague 1
Prineville 1
Quito 1
Rabat 1
Ribeirão Preto 1
Riga 1
Seattle 1
Serra Talhada 1
Springfield 1
São Paulo 1
Totale 470
Salva come PNG Salva come JPEG
Nome #
Bispecific aptamer-decorated and light-triggered nanoparticles targeting tumor and stromal cells in breast cancer derived organoids: implications for precision phototherapies 31
Inhibition of carbonic anhydrases IX/XII by SLC-0111 boosts cisplatin effects in hampering head and neck squamous carcinoma cell growth and invasion 28
Aptamer targeted therapy potentiates immune checkpoint blockade in triple-negative breast cancer 26
Mechanism of Action of Lactic Acid on Histones in Cancer 23
Inhibition of Bone Marrow-Mesenchymal Stem Cell-Induced Carbonic Anhydrase IX Potentiates Chemotherapy Efficacy in Triple-Negative Breast Cancer Cells 20
Optimizing cisplatin delivery to triple-negative breast cancer through novel EGFR aptamer-conjugated polymeric nanovectors 20
PATZ1 in Non-Small Cell Lung Cancer: A New Biomarker That Negatively Correlates with PD-L1 Expression and Suppresses the Malignant Phenotype 19
Selective Photo-Assisted Eradication of Triple-Negative Breast Cancer Cells through Aptamer Decoration of Doped Conjugated Polymer Nanoparticles 19
Aptamer-Functionalized Nanoparticles Mediate PD-L1 siRNA Delivery for Effective Gene Silencing in Triple-Negative Breast Cancer Cells 19
Novel Aptamers Selected on Living Cells for Specific Recognition of Triple-Negative Breast Cancer 18
Optimization of Short RNA Aptamers for TNBC Cell Targeting 18
Synthesis and functionalization of casein nanoparticles with aptamers for triple-negative breast cancer targeting 17
Subtype Transdifferenziation in Human Cancer: The Power of Tissue Plasticity in Tumor Progression 16
Aptamer-Based Strategies to Boost Immunotherapy in TNBC 16
Tissue Inhibitor of Metalloproteinases-1 Overexpression Mediates Chemoresistance in Triple-Negative Breast Cancer Cells 15
Aptamers and antibodies: rivals or allies in cancer targeted therapy? 15
Metabolic Reprogramming in Thyroid Cancer: Role of the Epithelial-Mesenchymal Transition 14
The Epithelial–Mesenchymal Transition at the Crossroads between Metabolism and Tumor Progression 14
PATZ1 is a new prognostic marker of glioblastoma associated with the stem-like phenotype and enriched in the proneural subtype 14
Affinity immobilization of aptamers on graphene oxide for biosensor applications 14
The POZ/BTB and AT-Hook Containing Zinc Finger 1 (PATZ1) Transcription Regulator: Physiological Functions and Disease Involvement 14
The Transcription Regulator Patz1 Is Essential for Neural Stem Cell Maintenance and Proliferation 14
Profiling cancer cells by cell-selex: Use of aptamers for discovery of actionable biomarkers and therapeutic applications thereof 13
Engineering Aptamers for Biomedical Applications: Part II 12
PATZ1 is a new prognostic marker of diffuse large B cell lymphomas 12
Aptamer-mediated impairment of EGFR-integrin alpha v beta 3 complex inhibits vasculogenic mimicry and growth of triple-negative breast cancers 11
Novel human bispecific aptamer-antibody conjugates for efficient cancer cell killing 11
Breakthroughs in medicinal chemistry: New targets and mechanisms, new drugs, new hopes-6 11
TNBC Challenge: Oligonucleotide Aptamers for New Imaging and Therapy Modalities 11
PATZ1 expression correlates positively with BAX and negatively with BCL6 and survival in human diffuse large B cell lymphomas 10
A novel antagonist of CXCR4 prevents bone marrow-derived mesenchymal stem cell-mediated osteosarcoma and hepatocellular carcinoma cell migration and invasion 10
Dual Oncogenic/Anti-Oncogenic Role of PATZ1 in FRTL5 Rat Thyroid Cells Transformed by the Ha-Ras(V12) Oncogene 9
Aptamers as innovative diagnostic and therapeutic agents in the central nervous system 9
PATZ1 is a target of miR-29b that is induced by Ha-Ras oncogene in rat thyroid cells 9
Aptamer targeting EGFRvIII mutant hampers its constitutive autophosphorylation and affects migration, invasion and proliferation of glioblastoma cells 9
Ferroptosis in Cancer: Epigenetic Control and Therapeutic Opportunities 8
Loss of one or two PATZ1 alleles has a critical role in the progression of thyroid carcinomas induced by the RET/PTC1 oncogene 8
Trabectedin modulates the senescence-associated secretory phenotype and promotes cell death in senescent tumor cells by targeting NF-?B 8
inhibition of bone marrow-derived mesenchymal stem cells homing towards triple-negative breast cancer microenvironment using an anti-PDGFRbeta aptamer 8
Targeted imaging and inhibition of triple-negative breast cancer metastases by a PDGFRbeta aptamer 8
Nucleic acid aptamers for in vivo molecular imaging 7
Aptamer Functionalization of Nanosystems for Glioblastoma Targeting through the Blood-Brain Barrier 6
Ipilimumab and its derived EGFR aptamer-based conjugate induce efficient NK cell activation against cancer cells 6
miR-34c may protect lung cancer cells from paclitaxel-induced apoptosis 6
Coupling aptamers to short interfering RNAs as therapeutics 6
Oligonucleotide aptamers against tyrosine kinase receptors: Prospect for anticancer applications 6
Aptamer-Based Technologies as New Tools for Proteomics in Diagnosis and Therapy Frontiers in Drug Design & Discovery 6
The Epithelial-to-Mesenchymal Transition in Breast Cancer: Focus on Basal-Like Carcinomas 6
The Tumor Suppressive Role of PATZ1 in Thyroid Cancer: A Matter of Epithelial-Mesenchymal Transition 6
Highlighting the potential of aptamer-based strategy to treat EGFRvIII-positive glioblastoma. Cancer Cell Microenviron. 6
A Neutralizing RNA Aptamer against EGFR Causes Selective Apoptotic Cell Death 6
Multifunctional Aptamer-miRNA Conjugates for Targeted Cancer Therapy 5
Inhibition of Receptor Signaling and of Glioblastoma-derived Tumor Growth by a Novel PDGFR beta Aptamer 5
cleic acids in human glioma treatment: innovative approaches and recent results 5
Targeting Axl With an High-affinity Inhibitory Aptamer 5
Shp2 in PC12 cells: NGF versus EGF 5
Inhibition of Receptor Signaling and of Glioblastoma-derived Tumor Growth by a Novel PDGFR? Aptamer. 5
Targeting cancer cells with nucleic acid aptamers 5
Cell-specific aptamers for targeted therapies. 5
GDNF selectively induces microglial activation and neuronal survival in CA1/CA3 hippocampal regions exposed to NMDA insult through Ret/ERK signalling. 4
Noncoding RNAs in Cancer Medicine. 4
Aptamers: Promising Tools for Cancer Diagnosis and Therapy 4
Proneural-mesenchymal transition: Phenotypic plasticity to acquire multitherapy resistance in glioblastoma 4
An Autocrine Loop Involving Ret and Glial Cell-Derived Neurotrophic Factor Mediates Retinoic Acid-Induced Neuroblastoma Cell Differentiation 4
Differential SELEX in human glioma cell lines. 4
PATZ1 Is Overexpressed in Pediatric Glial Tumors and Correlates with Worse Event-Free Survival in High-grade Gliomas 4
New insight into clinical development of nucleic acid aptamers. 4
Direct interactions among the tyrosine kinase receptor Ret, the GDNF and the GFR±1 molecules. 4
Recent advance in biosensors for microRNAs detection in cancer 4
Neutralizing aptamers from whole-cell SELEX inhibit the RET receptor tyrosine kinase 4
The isolectin IB4 binds RET receptor tyrosine kinase in microglia. 3
The chromosomal protein Sso7d of the crenarchaeon Sulfolobus solfataricus rescues aggregated proteins in an ATP hydrolysis-dependent manner 3
Breakthroughs in medicinal chemistry: New targets and mechanisms, new drugs, new hopes-7 3
A cross-talk between TrkB and Ret tyrosine kinases receptors mediates neuroblastoma cells differentiation. 3
Aptamers are an innovative and promising tool for phytoplankton taxonomy and biodiversity research 3
Distribution and bioactivity of the Ret-specific D4 aptamer in three-dimensional collagen gel cultures. 3
Totale 750
Salva come PNG Salva come JPEG
Categoria #
all - tutte 2.885
article - articoli 2.715
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 123
Totale 5.723
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/202458 0 0 0 0 0 0 0 0 5 0 20 33
2024/2025692 31 9 96 32 214 58 48 93 85 26 0 0
Totale 750